Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Nicholas Oesch
University of California, San Diego, Department: Ophthalmology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Nanovision Biosciences, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Oesch is a member of Advisory Board for Nanovision and holds less than (b)(4) of equity interest valued at (b)(4). Nanovision is developing a novel nanotechnology approach to retinal prosthesis. This project is to understand the basic response mechanisms produced by electrical stimulation from retinal prosthetic devices and how spared computational circuits are altered during retinal degeneration. Nanovision will be providing retinal prosthetic for use to study retinal disease in mice.
Computing Luminance and Contrast in Prosthetically Driven Retina
NARRATIVE A significant portion of patients suffering from irreversible blindness could benefit from prosthetic vision restoration. We can design better retinal prosthetics if we understand the basic response mechanisms produced by electrical stimulation from retinal prosthetic devices, and if we understand how spared computational circuits are altered during retinal degeneration. The results from this proposal will be significant and will inform strategies for stimulating retina to maximize vision restoration, in part by harnessing knowledge gained about how retinal circuits are altered during degeneration.
Filed on November 26, 2018.
Tell us what you know about Nicholas Oesch's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.